Abstract
Melanoma heterogeneity and plasticity underlie therapy resistance. Some tumour cells possess innate resistance while others reprogramme during drug exposure and survive to form persister cells, a source of potential cancer cells for recurrent disease. Tracing individual melanoma cell populations through tumour regression and recurrent disease remains largely unexplored, in part, because complex animal models are required for live imaging of cell populations over time. Here, we apply tamoxifen-inducible creERt2/loxP lineage tracing to a zebrafish model of MITF-dependent melanoma regression and recurrence to image and trace cell populations in vivo through disease stages. Using this strategy, we showed that melanoma persister cells at the minimal residual disease site originate from the primary tumour. Next, we fate mapped rare MITF-independent persister cells and demonstrate that these cells directly contribute to progressive disease. Multiplex immunohistochemistry confirmed MITF-independent persister cells give rise to Mitfa+ cells in recurrent disease. Taken together, our work reveals a direct contribution of melanoma persister cell populations to recurrent disease, and provides a resource for lineage tracing methodology in adult zebrafish cancer models.
Summary statement We fate map melanoma cells from the primary tumour into a persister cell state and show that persister cells directly contribute to recurrent disease.
Competing Interest Statement
The authors have declared no competing interest.
